![Larry Hansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Larry Hansen
Keine laufenden Positionen mehr
Profil
Larry Hansen worked as an Executive Director of National Sales at Prometheus Laboratories, Head of Sales at Procter & Gamble Co., Vice President of Commercial Operations at Biotheranostics, Chief Commercial Officer at Aviir, and Head of Sales at Novartis Nutrition Corp.
He completed his undergraduate degree at the University of Wisconsin.
Ehemalige bekannte Positionen von Larry Hansen
Unternehmen | Position | Ende |
---|---|---|
Aviir, Inc.
![]() Aviir, Inc. Medical/Nursing ServicesHealth Services Aviir, Inc. discovers, develops and commercializes diagnostic laboratory tests for cardiovascular diseases. The biotechnology company specializes in developing proprietary diagnostic tests to assist in identifying patients who are truly at high risk for the development of a cardiac event. The company was founded in 2005 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 16.04.2014 |
Prometheus Laboratories, Inc.
![]() Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Vertrieb & Marketing | - |
PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - |
Novartis Nutrition Corp. | Corporate Officer/Principal | - |
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Geschäftsführer | - |
Ausbildung von Larry Hansen
University of Wisconsin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
Private Unternehmen | 4 |
---|---|
Biotheranostics, Inc.
![]() Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
Novartis Nutrition Corp. | |
Aviir, Inc.
![]() Aviir, Inc. Medical/Nursing ServicesHealth Services Aviir, Inc. discovers, develops and commercializes diagnostic laboratory tests for cardiovascular diseases. The biotechnology company specializes in developing proprietary diagnostic tests to assist in identifying patients who are truly at high risk for the development of a cardiac event. The company was founded in 2005 and is headquartered in Irvine, CA. | Health Services |
Prometheus Laboratories, Inc.
![]() Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |